These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24402195

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM, Collins KL, Diamond MP.
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients.
    Betancourt MT, Rodger MA.
    Acta Chir Belg; 2007 Dec; 107(6):636-40. PubMed ID: 18274176
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA, D-dimer Optimal Duration Study Investigators.
    Ann Intern Med; 2015 Jan 06; 162(1):27-34. PubMed ID: 25560712
    [Abstract] [Full Text] [Related]

  • 29. Clinical characteristics and outcomes of patients with multiple simultaneous superficial vein thrombi.
    Chopra R, Leon LR, Labropoulos N.
    J Vasc Surg Venous Lymphat Disord; 2018 Jul 06; 6(4):485-491. PubMed ID: 29678687
    [Abstract] [Full Text] [Related]

  • 30. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S, Mao RL, Couturaud F, Lacut K, Delluc A.
    Thromb Haemost; 2019 Mar 06; 119(3):490-495. PubMed ID: 30685873
    [Abstract] [Full Text] [Related]

  • 31. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF, Barron G, Meliton A, Mutlu GM, Dulin NO, Schuger L.
    Am J Respir Cell Mol Biol; 2019 Feb 06; 60(2):221-231. PubMed ID: 30230348
    [Abstract] [Full Text] [Related]

  • 32. Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study.
    Traby L, Kollars M, Eischer L, Eichinger S, Kyrle PA.
    PLoS One; 2012 Feb 06; 7(12):e51447. PubMed ID: 23240024
    [Abstract] [Full Text] [Related]

  • 33. Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism.
    Potaczek DP, Jankowska EA, Wypasek E, Undas A.
    Pol Arch Med Wewn; 2016 Feb 06; 126(3):159-65. PubMed ID: 26942727
    [Abstract] [Full Text] [Related]

  • 34. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI, García Navarro MJ, Ortiz Sánchez J, Martín Díaz RM, Madroñal Cerezo E, de Ancos Aracil CL, Cabello Clotet N, Perales Fraile I, Gimeno García S, Montero Hernández C, Zapatero Gaviria A, Ruiz Giardín JM.
    Eur J Intern Med; 2016 Apr 06; 29():59-64. PubMed ID: 26775136
    [Abstract] [Full Text] [Related]

  • 35. Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.
    Sundquist K, Ahmad A, Svensson PJ, Zöller B, Sundquist J, Memon AA.
    J Thromb Thrombolysis; 2018 Aug 06; 46(2):154-165. PubMed ID: 29671165
    [Abstract] [Full Text] [Related]

  • 36. Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism.
    White RH, Murin S, Wun T, Danielsen B.
    J Thromb Haemost; 2010 May 06; 8(5):987-97. PubMed ID: 20149075
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
    Ljungqvist M, Sonnevi K, Bergendal A, Holmström M, Kieler H, Lärfars G.
    Thromb Res; 2014 May 06; 133(5):762-7. PubMed ID: 24613699
    [Abstract] [Full Text] [Related]

  • 38. Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma.
    Seystahl K, Papachristodoulou A, Burghardt I, Schneider H, Hasenbach K, Janicot M, Roth P, Weller M.
    Mol Cancer Ther; 2017 Jun 06; 16(6):1177-1186. PubMed ID: 28377490
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer.
    Satpanich P, Rojnuckarin P.
    Hematology; 2019 Dec 06; 24(1):159-165. PubMed ID: 30334695
    [Abstract] [Full Text] [Related]

  • 40. Regulation of colony-stimulating factor-induced human myelopoiesis by transforming growth factor-beta isoforms.
    Salzman SA, Mazza JJ, Burmester JK.
    Cytokines Cell Mol Ther; 2002 Mar 06; 7(1):31-6. PubMed ID: 12171249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.